Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
about
The pharmacological landscape and therapeutic potential of serine hydrolasesEssential Roles of Natural Products and Gaseous Mediators on Neuronal Cell Death or SurvivalRivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening.Combined QSAR studies of inhibitor properties of O-phosphorylated oximes toward serine esterases involved in neurotoxicity, drug metabolism and Alzheimer's disease.Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Acetylcholinesterase inhibitors: pharmacology and toxicology.Effects of Launaea procumbens on brain antioxidant enzymes and cognitive performance of ratDiscovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.The metabolic serine hydrolases and their functions in mammalian physiology and disease.New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenineA 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.Effect of pesticide bendiocarbamate on distribution of acetylcholine- and butyrylcholine-positive nerves in rabbit's thymus.Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer DiseaseBrain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats: efficiency of Sonchus asper.Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.Age-related changes in rostral basal forebrain cholinergic and GABAergic projection neurons: relationship with spatial impairmentAn update on huperzine A as a treatment for Alzheimer's disease.Impaired cognition and attention in adults: pharmacological management strategies.Current and future therapy in Alzheimer's disease.Tau-based treatment strategies in neurodegenerative diseasesProteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition.Cholinergic functioning in stimulant addiction: implications for medications development.Current perspectives on pharmacotherapy of Alzheimer's disease.Huprines for Alzheimer's disease drug development.New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.Dantrolene, a treatment for Alzheimer disease?New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.3-(Benzyloxy)-1-(5-[18F]fluoropentyl)-5-nitro-1H-indazole: a PET radiotracer to measure acetylcholinesterase in brain.Diverse Molecular Targets for Chalcones with Varied Bioactivities.Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology.Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs.Progress in the development of new drugs in Alzheimer's disease.Effects of Mimosa pudica L. leaves extract on anxiety, depression and memory.Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats.Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels.
P2860
Q26995817-3C4FBAF9-0775-49B2-91C6-FBB01F1127DCQ28078276-5871EDB1-A50F-420F-9B17-88F5E17C6804Q33596451-6ADE77C4-50C5-42AB-8320-3D802A736BF2Q33715239-C01F3654-C7DF-4784-BD90-B8C3A7DB5235Q33890728-747F1877-E93A-44BC-8DAD-C6C562E74077Q34269625-B20B1240-7DFF-47A0-91D2-3FD90D89FF32Q34327769-A61464BB-D5D4-44EE-82F5-5A747782EDC3Q34381860-BD6CD373-D5B1-43E9-9C24-5B6F74E7D21DQ34476570-5662FDB5-0A49-49BB-AFBD-DE60A31459D9Q35130541-37E35EDC-DD63-4AB6-BC02-D74BD4AF8D0CQ35333042-29C3C1B8-4F89-4309-9073-83B60286ED13Q35382061-801F5F55-C154-48BB-9024-BC05D9DD19ACQ35428213-9F787B5E-ABFF-43D3-ADD3-D9EDAEE5ACF1Q35617556-8175EDD5-2891-47F9-B9AC-B7CDA7B27FFAQ35771424-73522C10-56BC-45EA-A04F-D26648345073Q36273566-FE485182-5881-4BFC-AC37-954A8353244CQ36480169-DD499E2B-E8A5-476D-8FB8-20AB24E34040Q36678091-493F4DF3-8DA5-4AE6-9078-4D17043E6C85Q36784073-B49682B6-C10A-4721-AF1E-43AAF06F2FC7Q37071192-EB7A2AF8-5B15-4154-9B9B-1BBC7268C575Q37125488-54D1FD4E-9FDE-4230-854F-05C0518A0F52Q37165703-9748C355-25AC-4FC1-AA3B-FE5497DD455DQ37215861-9553F35F-2F28-4AA1-9853-E90ACCB7AF7CQ37251595-89B4FC0A-A405-45ED-96C9-684982AB42CCQ37618780-5AFC5112-B8A4-4F33-A954-B41074F31E89Q37827489-3B29ABCF-1703-45A2-9720-CB682FF391E1Q38088283-2527FC22-3E3C-4713-A142-827E42029926Q38099889-033D193E-F60D-49E6-ADA0-302C08CFB53BQ38304771-8641EBED-B488-4CD6-8CD5-0ECAB0E80121Q38395251-2B4BF654-9D1C-448D-940F-FB482ADF4798Q38669027-5C3ABE29-ABF0-4E8E-B083-C39365904D80Q38707609-E2E95D45-23E6-43F6-97AE-5BCF5CFC9F09Q38778876-76A1B2BA-D609-4667-B0DA-31BE233C3DE4Q38850493-C19345E2-82EB-498A-9FCE-2B2FC9A19B38Q39229873-932A2C8E-3D3C-4BC7-ADAF-E1EFB01696B7Q39438767-50ADD56C-F883-4246-A5FB-50A78FD2FA96Q39789745-A0D53E6B-136E-4D06-BDD2-C6CC8F7F9E12Q40553725-8AD98A64-46EC-4D40-AA8D-0F3DACE608A9Q41873816-086AF441-098B-4865-9060-D97DB1BE826EQ42055242-ADC00944-6FA7-484B-8417-9F3F73BEBE10
P2860
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@ast
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@en
type
label
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@ast
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@en
prefLabel
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@ast
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@en
P1476
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
@en
P2093
Albert Enz
Roger M Lane
P304
P356
10.1017/S1461145705005833
P577
2005-08-05T00:00:00Z